Cambridge University's needle-free Covid vaccine enters clinical trials.
Clinical trials for a needle-free vaccine, DIOS-CoVax, developed by Professor Jonathan Heeney at the University of Cambridge and spin-out company DIOSynVax, have begun in Cambridge. The vaccine is designed to protect against SARS-CoV-2 and related coronaviruses and is administered through a blast of air that delivers it into the skin. If successful, the vaccine could be scaled up and manufactured as a powder to boost global vaccination efforts. The clinical trials team is looking for healthy volunteers aged 18-50 to take part in the study.